These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12958004)

  • 1. Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia.
    Verhey FR; Huppert FA; Korten EC; Houx P; de Vugt M; van Lang N; DeDeyn PP; Saerens J; Neri M; de Vreese L; Peña-Casanova J; Böhm P; Stoppe G; Fleischmann U; Wallin A; Hellström P; Middelkoop H; Bollen W; Klinkenberg EL; Derix MM; Jolles J
    Age Ageing; 2003 Sep; 32(5):534-40. PubMed ID: 12958004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG).
    Hon J; Huppert FA; Holland AJ; Watson P
    Br J Clin Psychol; 1999 Jun; 38(2):155-65. PubMed ID: 10389597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of the Brazilian version of the informant questionnaire on cognitive decline in the elderly at screening for dementia in community-dwelling elderly participants: findings from FIBRA-RJ study.
    Lourenço RA; Sanchez MA
    J Geriatr Psychiatry Neurol; 2014 Sep; 27(3):212-9. PubMed ID: 24614204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting prodromal Alzheimer's disease in mild cognitive impairment: utility of the CAMCOG and other neuropsychological predictors.
    Gallagher D; Mhaolain AN; Coen R; Walsh C; Kilroy D; Belinski K; Bruce I; Coakley D; Walsh JB; Cunningham C; Lawlor BA
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1280-7. PubMed ID: 21086538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of the Brazilian version of the Cambridge Cognitive Examination Revised CAMCOG-R.
    Paradela EM; Lopes Cde S; Lourenço RA
    Arq Neuropsiquiatr; 2009 Jun; 67(2B):439-44. PubMed ID: 19623441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Cambridge Cognitive Examination as a tool for detection of dementia].
    Lozano-Gallego M; Vilalta-Franch J; Llinàs-Reglà J; López-Pousa S
    Rev Neurol; 1999 Feb 16-28; 28(4):348-52. PubMed ID: 10714310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer's disease: a cross-sectional study.
    Cecato JF; Melo BAR; Moraes GC; Martinelli JE; Montiel JM
    Sao Paulo Med J; 2018; 136(5):390-397. PubMed ID: 30570090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the CAMCOG, the MMSE, and three clock drawing tests in a specialized outpatient psychogeriatric service.
    Heinik J; Solomesh I; Berkman P
    Arch Gerontol Geriatr; 2004; 38(1):77-84. PubMed ID: 14599707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the efficiency of the mini-Kingston standardized cognitive assessment-revised in classifying patients according to DSM-5 major and mild neurocognitive disorders due to possible Alzheimer's disease.
    Heinik J; Kavé G
    Int Psychogeriatr; 2015 May; 27(5):785-91. PubMed ID: 25597552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
    Kessels RP; Mimpen G; Melis R; Rikkert MG
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological subgroups of dementia of the Alzheimer's type.
    Williams RN; McIntosh DE; Eells GT; Dean RS; Hendrie H
    Int J Neurosci; 1996 Oct; 87(1-2):79-90. PubMed ID: 8913821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Cambridge Cognitive Examination - revised a good tool for detection of dementia in illiterate Brazilian older adults?
    Paradela EM; Lourenço RA
    Geriatr Gerontol Int; 2014 Oct; 14(4):763-8. PubMed ID: 24666650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of Alzheimer's disease using the Cambridge Cognitive Examination (CAMCOG).
    Schmand B; Walstra G; Lindeboom J; Teunisse S; Jonker C
    Psychol Med; 2000 May; 30(3):619-27. PubMed ID: 10883717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment: cognitive screening or neuropsychological assessment?
    Diniz BS; Nunes PV; Yassuda MS; Pereira FS; Flaks MK; Viola LF; Radanovic M; Abreu ID; Borelli DT; Gattaz WF; Forlenza OV
    Braz J Psychiatry; 2008 Dec; 30(4):316-21. PubMed ID: 19142405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinician and caregiver agreement on neuropsychiatric symptom severity: a study using the Neuropsychiatric Inventory - Clinician rating scale (NPI-C).
    Zaidi S; Kat MG; de Jonghe JF
    Int Psychogeriatr; 2014 Jul; 26(7):1139-45. PubMed ID: 24622334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.